IL-8 receptor antagonists
US6221889A · kind A · utility
3Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2000 |
| Grant date | Apr 24, 2001 |
| Priority date | — |
| Expiry date | Jul 14, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides for a method of treating a chemokine mediated disease, wherein the chemokine is one which binds to an IL-8 .alpha. or .beta. receptor and which method comprises administering an effective amount of a compound of Formular (I) or a pharmaceuticlly acceptable salt thereof. In particular the chemokine is IL-8. ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.